Novorapid

From Wikipedia, the free encyclopedia

This article is orphaned as few or no other articles link to it. Please help introduce links in articles on related topics. (November 2006)

Novorapid is a bolus insulin analogue created by Novo Nordisk. It is of rDNA origin. It is sold under the name 'Novolog' in the United States.

It has become a widely-used replacement for the now defunct Actrapid insulin,^{[citation needed]} as it has very similar properties. One problem with this insulin though is that it has to be administered in double the quantity that Actrapid was,^{[citation needed]} although this is only a small problem.

It has a reaction time of around 25–35 minutes, depending on the physical size of the person taking it. This means it is known as "fast-acting".

[edit] External links

• Novorapid